NCT07535359 Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer Status AVAILABLE Phase N/A
NCT07508852 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07416695 A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC Status RECRUITING Phase PHASE1
NCT07145333 Pharmacogenomics ANDA SNP Clinical Study - Topotecan and Single Nucleotide Polymorphisms Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT07110103 Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC Status RECRUITING Phase PHASE2
NCT06820762 Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study Status NOT_YET_RECRUITING Phase PHASE2
NCT06657222 First in Human Study of TUB-030 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06616532 PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06534762 Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study Status RECRUITING Phase PHASE2
NCT06441344 Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell Status NOT_YET_RECRUITING Phase PHASE3
NCT06179069 A Study of ZL-1310 in Subjects With Small Cell Lung Cancer Status RECRUITING Phase PHASE1
NCT06116019 Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS) Status RECRUITING Phase N/A
NCT06021483 Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection Status RECRUITING Phase N/A
NCT05903092 MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT05879068 A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05844150 A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05703269 Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy Status ACTIVE_NOT_RECRUITING Phase NA